
LLY • NYSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold LLY in your mock portfolio yet.
A PE ratio of 44.52 and EPS of 22.92 imply strong current earnings power and that the market is willing to pay a premium for Eli Lilly’s growth and profitability. While the valuation is elevated versus the broader market, it is consistent with a high-growth, high-margin pharma leader with strong product momentum (e.g., in obesity and diabetes). Profitability metrics suggest investors are pricing in durable earnings expansion rather than cyclical or one‑off gains.
The stock trades around $1,000, about 6% below its level a month ago, but still well above its 200‑day moving average of $857.33, indicating a strong longer‑term uptrend. However, the RSI at 87.84 is deep into overbought territory, suggesting elevated risk of near‑term consolidation or pullback even if the longer‑term trend remains positive.
Alternative data show a broadly healthy and expanding corporate and brand footprint. Web traffic is substantial, job openings remain high despite a small MoM decline, and social media followings across major platforms are growing, indicating sustained interest from professionals, patients, and the broader public.
Overall signals for Eli Lilly and Company are bullish: strong earnings and a premium valuation, a price well above its 200‑day moving average, and robust alternative data all point to a company with sustained growth momentum. The main caution is technical overextension, with an extremely high RSI suggesting the potential for short‑term volatility or pullback even within a favorable long‑term setup.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Eli Lilly and Company (LLY) has experienced a slight price change of 0.0% over the last day, but a notable decline of 3.8% over the past week. Despite this, there has been a slight increase in Reddit mentions, up 6% compared to the 7-day average, which may indicate growing interest among retail investors. The upcoming earnings date is set for February 4, 2026, which could also be contributing to the current attention on the stock.
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: